Stay updated with the latest science news and analysis
University of Queensland researchers have developed a groundbreaking oral anti-inflammatory drug for Parkinson's disease, showing promise in mouse models by reducing brain inflammation and protecting dopamine-producing neurons. This novel compound targets inflammasomes, offering a significant step towards disease-modifying treatments that could halt progression rather than just managing symptoms.
Penn State researchers have achieved a significant scientific milestone by successfully creating seven previously unknown high-entropy oxides (HEOs) through a novel "oxygen hack" that precisely manipulates oxygen levels during material synthesis. This innovative method promises to revolutionize the development of advanced ceramic materials, offering immense potential for applications in energy storage, advanced electronics, and durable protective coatings.
Earth's orbital environment faces an escalating threat from space debris, with defunct satellites and rocket stages posing a danger to vital space-based services and risking a catastrophic "Kessler Syndrome." To combat this, researchers advocate for a "circular space economy" focused on repair, reuse, and recycling, alongside new technologies for active debris removal and significant initiatives from international space agencies.
Researchers from the University of Tokyo have potentially made a groundbreaking discovery, detecting a halo of high-energy gamma rays that strongly aligns with theoretical predictions for dark matter particle annihilation, possibly marking humanity's first direct observation of the elusive substance. This exciting finding, led by Professor Tomonori Totani, suggests dark matter could be a new particle beyond the Standard Model, though experts emphasize the critical need for independent verification.
Merck is poised to unveil crucial first-in-human data for its investigational Alzheimer's drug candidates, MK-2214 and MK-1167, at the prestigious Clinical Trials on Alzheimer's Disease (CTAD) 2025 conference in San Diego. Adding to this momentum, MK-2214 has already secured FDA Fast Track Designation, accelerating its development in the urgent fight against this debilitating disease.
Researchers have unveiled a surprising new role for Hormone-Sensitive Lipase (HSL), discovering it not only breaks down fat but also maintains fat cell function from within the nucleus, challenging long-held scientific assumptions. This pivotal finding, which reveals HSL deficiency leads to fat loss rather than accumulation, offers critical insights into metabolic disorders like obesity and lipodystrophy, potentially revolutionizing their understanding and treatment.
UK doctors have announced a significant breakthrough in treating Huntington's disease with the new gene therapy AMT-130, which demonstrated an impressive 75 percent slowing of disease progression in early-stage clinical trials. This groundbreaking development offers substantial hope for patients by targeting the root cause of the devastating neurodegenerative disorder, potentially ushering in a new era of treatment.
A groundbreaking gene therapy, AMT-130, has demonstrated remarkable potential by significantly slowing the progression of Huntington's disease by 75% in a pivotal Phase I/II clinical study, offering substantial hope for patients with this devastating neurodegenerative disorder. However, despite these promising results, the U.S. FDA recently indicated that the external control data from these studies are no longer considered adequate for a Biologics License Application, introducing uncertainty into its approval timeline.
Scientists at the University of Tokyo, led by Professor Tomonori Totani, have potentially discovered the first direct observational evidence of dark matter by identifying a distinctive halo of high-energy gamma rays using NASA's Fermi Gamma-ray Space Telescope. This groundbreaking finding, which aligns with theoretical predictions for dark matter particle annihilation, could fundamentally rewrite our understanding of the universe and offers a direct glimpse into the elusive substance that has puzzled scientists for decades.
In a monumental leap for sustainable energy, France's WEST facility shattered a world record on February 12, 2025, by sustaining a nuclear fusion plasma for an unprecedented 1,337 seconds, or over 22 minutes. This remarkable achievement, reaching 50 million degrees Celsius, significantly advances the global pursuit of fusion power by demonstrating critical long-duration plasma control and material resilience necessary for future commercial reactors.
In 2025, cancer research achieved significant milestones, introducing a new era of more precise, effective, and less toxic therapies that foster widespread optimism in the fight against cancer. This remarkable progress was fueled by intensified global collaboration and breakthroughs in areas such as immunotherapy, including bispecific antibodies and advanced CAR T-cell therapies, alongside the transformative integration of artificial intelligence in diagnosis and treatment planning.
NASA's Perseverance rover has made a groundbreaking discovery, detecting the first electrical activity, or "mini-lightning," in the Martian atmosphere, primarily associated with dust devils and storms. This significant finding adds Mars to the exclusive list of planets known to exhibit atmospheric electrical activity, with profound implications for understanding its climate, chemistry, and future exploration efforts.